ANGLE plc (AGL):企業の製品パイプライン分析2018

◆英語タイトル:ANGLE plc (AGL) - Product Pipeline Analysis, 2018 Update
◆商品コード:DATA904C12783
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥163,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥245,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ANGLE Plc (ANGLE) is a medical diagnostic company that offers cancer diagnostics and foetal health products. The company develops products for use in rare cell diagnostics that enable early, accurate identification of an individual’s condition for the prevention, treatment, and monitoring of disease. Its product Parsortix cell separation system, which captures very rare circulating tumor cells in cancer patient blood. ANGLE’s Parsortix cell separation system uses a microfluidic technology in the form of a one-time use cassette to capture and then harvest circulating tumor cells (CTCs) from blood. The company’s cassette captures CTCs based on their less deformable nature and larger size compared to other blood components. It provides liquid biopsy (blood test) that enables the detection and investigation of mutations in the patient’s cancer for personalized cancer care. The company’s harvested CTCs have a range of applications such as diagnosis, prognosis, mutational analysis and drug selection, drug development, assessment of treatment effectiveness and remission monitoring. It has operations in the US and the UK. ANGLE is headquartered in Guildford, the UK.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company ANGLE plc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
ANGLE plc Company Overview 5
ANGLE plc Company Snapshot 5
ANGLE plc Pipeline Products and Ongoing Clinical Trials Overview 5
ANGLE plc – Pipeline Analysis Overview 8
ANGLE plc – Key Facts 8
ANGLE plc – Major Products and Services 9
ANGLE plc Pipeline Products by Development Stage 10
ANGLE plc Ongoing Clinical Trials by Trial Status 12
ANGLE plc Pipeline Products Overview 14
Parsortix GEN2 14
Parsortix GEN2 Product Overview 14
Parsortix System 15
Parsortix System Product Overview 15
Parsortix-Based Test – Breast Cancer 16
Parsortix-Based Test – Breast Cancer Product Overview 16
Parsortix-Based Test – Colorectal Cancer 17
Parsortix-Based Test – Colorectal Cancer Product Overview 17
Parsortix-Based Test – Head & Neck Cancer 18
Parsortix-Based Test – Head & Neck Cancer Product Overview 18
Parsortix-Based Test – Lung Cancer 19
Parsortix-Based Test – Lung Cancer Product Overview 19
Parsortix-Based Test – Ovarian Cancer Triage 20
Parsortix-Based Test – Ovarian Cancer Triage Product Overview 20
Parsortix-Based Test – Ovarian Cancer Triage Clinical Trial 21
Parsortix-Based Test – Pancreatic Cancer 22
Parsortix-Based Test – Pancreatic Cancer Product Overview 22
Parsortix-Based Test – Prostate Cancer 23
Parsortix-Based Test – Prostate Cancer Product Overview 23
ANGLE plc – Key Competitors 24
ANGLE plc – Key Employees 25
ANGLE plc – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 27
ANGLE plc, Recent Developments 27
Jun 04, 2018: ANGLE: Encouraging Progress in ANG-002 FDA Clinical Study 27
May 14, 2018: Angle Appoints Leading NHS Prostate Cancer Surgeon As Scientific Advisor 27
May 03, 2018: Angle and Qiagen Present Poster at Leading Cancer Conference Demonstrating Utility of Angle”s Parsortix System in Conjunction With Qiagen”s Adnatest Assay 28
Apr 19, 2018: Angle”s Parsortix System Showcased In Multiple Presentations At Leading Cancer Conference AACR 2018 28
Apr 19, 2018: Breakthrough Research Demonstrates Parsortix Workflow For Culturing Circulating Tumor Cells For In-Vitro Drug Testing 29
Apr 05, 2018: First Patient Enrolled In Clinical Study To Support FDA Clearance Of The Parsortix System 30
Mar 26, 2018: Angle”S Ovarian Cancer Risk Assessment Achieves The Highest Sensitivity And Specificity For Predicting Cancer 30
Feb 06, 2018: ANGLE: Research Grant From Abbott 31
Jan 31, 2018: ANGLE: Interim Results for the six months ended 31 October 2017 32
Jan 16, 2018: ANGLE: Webinar: Using The Parsortixtm System To Identify Drugs That May Arrest Cancer Metastasis 33
Appendix 34
Methodology 34
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
ANGLE plc Pipeline Products and Ongoing Clinical Trials Overview 5
ANGLE plc Pipeline Products by Equipment Type 6
ANGLE plc Pipeline Products by Indication 7
ANGLE plc Ongoing Clinical Trials by Trial Status 7
ANGLE plc, Key Facts 8
ANGLE plc, Major Products and Services 9
ANGLE plc Number of Pipeline Products by Development Stage 10
ANGLE plc Pipeline Products Summary by Development Stage 11
ANGLE plc Ongoing Clinical Trials by Trial Status 12
ANGLE plc Ongoing Clinical Trials Summary 13
Parsortix GEN2 - Product Status 14
Parsortix GEN2 - Product Description 14
Parsortix System - Product Status 15
Parsortix System - Product Description 15
Parsortix-Based Test - Breast Cancer - Product Status 16
Parsortix-Based Test - Breast Cancer - Product Description 16
Parsortix-Based Test - Colorectal Cancer - Product Status 17
Parsortix-Based Test - Colorectal Cancer - Product Description 17
Parsortix-Based Test - Head & Neck Cancer - Product Status 18
Parsortix-Based Test - Head & Neck Cancer - Product Description 18
Parsortix-Based Test - Lung Cancer - Product Status 19
Parsortix-Based Test - Lung Cancer - Product Description 19
Parsortix-Based Test - Ovarian Cancer Triage - Product Status 20
Parsortix-Based Test - Ovarian Cancer Triage - Product Description 20
Parsortix-Based Test - Ovarian Cancer Triage - Evaluation of Multiple Protein and Molecular Biomarkers to Estimate Risk of Cancer in Gynecology Patients Presenting with a Pelvic Mass: ANG-003 EMBER Study 21
Parsortix-Based Test - Pancreatic Cancer - Product Status 22
Parsortix-Based Test - Pancreatic Cancer - Product Description 22
Parsortix-Based Test - Prostate Cancer - Product Status 23
Parsortix-Based Test - Prostate Cancer - Product Description 23
ANGLE Plc, Key Employees 25
ANGLE Plc, Other Locations 26
Glossary 36

List of Figures
ANGLE plc Pipeline Products by Equipment Type 6
ANGLE plc Pipeline Products by Development Stage 10
ANGLE plc Ongoing Clinical Trials by Trial Status 12

★海外企業調査レポート[ANGLE plc (AGL):企業の製品パイプライン分析2018]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Euronet Worldwide, Inc.:企業の戦略・SWOT・財務情報
    Euronet Worldwide, Inc. - Strategy, SWOT and Corporate Finance Report Summary Euronet Worldwide, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Georgetown University:製薬・医療:M&Aディール及び事業提携情報
    Summary Georgetown University (GU) is an academic and research institute that offers educational services. The university provides undergraduate and graduate degree programs in the fields of law, medical, medical residencies, business administration and public policy degrees, post-doctoral positions …
  • Eco2 Ltd:企業のM&A・提携動向(エネルギー分野)
    Summary Eco2 Ltd (Eco2) is a renewable energy company that develops, finances and operates renewable energy projects. The company generates electricity from wind. It manages fuel logistics and administration of Western Wood Energy Plant, which is wood fired project located in Port Talbot, South Wale …
  • Norwegian Air Shuttle AS:企業の戦略・SWOT・財務分析
    SummaryNorwegian Air Shuttle AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Ke …
  • Medpace Inc (MEDP):企業財務及び戦略的SWOT分析
    Summary Medpace Inc (Medpace), a subsidiary of Medpace Holdings, Inc. is a contract research organization that develops research based drug and medical device. The company’s services include clinical trial management, regulatory consulting, regulatory submissions, investigator selection, clinical mo …
  • Atwood Oceanics, Inc. (ATW):企業のM&A・提携動向(石油・ガス分野)
    Summary Atwood Oceanics, Inc. (Atwood) is an offshore drilling contractor, which offers drilling and completion solutions to the oil and gas industry. The company owns a diversified fleet of mobile offshore drilling units in the US Gulf of Mexico, the Mediterranean Sea, offshore West Africa, offshor …
  • ZWACK Unicum Nyrt:戦略・SWOT・企業財務分析
    ZWACK Unicum Nyrt - Strategy, SWOT and Corporate Finance Report Summary ZWACK Unicum Nyrt - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • India Cements Limited (INDIACEM):企業の財務及び戦略的SWOT分析
    Summary India Cements Limited (India Cements) is a construction products company that produces and distributes cement. The company offers products such as cement and ready mix concrete. Its products are used as concrete in RCC works, paving blocks, tiles building blocks, runways, concrete roads, bri …
  • CaridianBCT, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' CaridianBCT, Inc. Mergers and A …
  • Quantum Materials Corporation (formerly Hague Corporation):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Quantum Materials Corporation ( …
  • Imagineer Co., Ltd. (4644):企業の財務及び戦略的SWOT分析
    Summary Imagineer Co., Ltd. (Imagineer) is an information technology company that offers software products. The company designs, develops and commercializes gaming software and computer peripherals. Its products include mobile commerce, package software and education software. Imagineer provides ser …
  • Mitsui Oil Exploration Co., Ltd.:企業の戦略的SWOT分析
    Mitsui Oil Exploration Co., Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Heinzel Holding GmbH:企業の戦略的SWOT分析
    Heinzel Holding GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Sandvik AB:企業の戦略・SWOT・財務分析
    Sandvik AB - Strategy, SWOT and Corporate Finance Report Summary Sandvik AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • INPEX Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' INPEX Corporation Mergers and A …
  • Tocris Bioscience:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Tocris Bioscience Mergers and A …
  • Senhwa Biosciences Inc (6492):製薬・医療:M&Aディール及び事業提携情報
    Summary Senhwa Biosciences Inc (Senhwa) is a clinical stage drug development company that develops next generation DNA damage response drugs for the treatment of cancer. The company’s pipeline products include CX-5461 and CX-4945. Its CX-5461, a G4-stabilizing compound, is a Pol I inhibitor that tri …
  • TAS S.p.A. (TAS):企業概要、財務及び戦略的SWOT分析
    Summary TAS S.p.A. (TAS) is a software developer. The company provides software solutions for electronic banking, payments and financial markets. Its services include card management, payment networks access and order management services. TAS’ solutions include continuous development of applications …
  • Welcome Break Group Limited:企業の戦略・SWOT・財務分析
    SummaryWelcome Break Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. …
  • ELAN Microelectronics Corp.の企業概要及び財務/SWOT分析
    ELAN Microelectronics Corp. Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and qua …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆